The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

Cobbold JF, Miller H, Hallsworth K, Manousou P, Marjot T, Allison MED, Anstee QM, Armstrong MJ, Avery L, Azzu V, Brennan PN, Byrne CD, Cacciottolo TM, Corless L, Forton D, Hardy T, Hebditch V, Jarvis H, Li W, Mansour D, McPherson S, Miao Y, Morling J, Mukhopadhya A, Mullish B, Parker R, Patanwala I, Patel J, Pavlides M, Reinson T, Rowe IA, Saffioti F, Shaikh F, Srivastava A, Than NN, Tsochatzis E, Volcek E, Tomlinson JW, Alazawi W

Open source

DOI: 10.1016/s2468-1253(26)00077-4
Published: 2026 Jul
Container: The lancet. Gastroenterology & hepatology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-26-00077-4,
  title = {The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.},
  author = {Cobbold JF and Miller H and Hallsworth K and Manousou P and Marjot T and Allison MED and Anstee QM and Armstrong MJ and Avery L and Azzu V and Brennan PN and Byrne CD and Cacciottolo TM and Corless L and Forton D and Hardy T and Hebditch V and Jarvis H and Li W and Mansour D and McPherson S and Miao Y and Morling J and Mukhopadhya A and Mullish B and Parker R and Patanwala I and Patel J and Pavlides M and Reinson T and Rowe IA and Saffioti F and Shaikh F and Srivastava A and Than NN and Tsochatzis E and Volcek E and Tomlinson JW and Alazawi W},
  year = {2026},
  journal = {The lancet. Gastroenterology \& hepatology},
  doi = {10.1016/s2468-1253(26)00077-4},
  url = {https://doi.org/10.1016/s2468-1253(26)00077-4}
}

RIS

TY  - JOUR
TI  - The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.
AU  - Cobbold JF
AU  - Miller H
AU  - Hallsworth K
AU  - Manousou P
AU  - Marjot T
AU  - Allison MED
AU  - Anstee QM
AU  - Armstrong MJ
AU  - Avery L
AU  - Azzu V
AU  - Brennan PN
AU  - Byrne CD
AU  - Cacciottolo TM
AU  - Corless L
AU  - Forton D
AU  - Hardy T
AU  - Hebditch V
AU  - Jarvis H
AU  - Li W
AU  - Mansour D
AU  - McPherson S
AU  - Miao Y
AU  - Morling J
AU  - Mukhopadhya A
AU  - Mullish B
AU  - Parker R
AU  - Patanwala I
AU  - Patel J
AU  - Pavlides M
AU  - Reinson T
AU  - Rowe IA
AU  - Saffioti F
AU  - Shaikh F
AU  - Srivastava A
AU  - Than NN
AU  - Tsochatzis E
AU  - Volcek E
AU  - Tomlinson JW
AU  - Alazawi W
PY  - 2026
JO  - The lancet. Gastroenterology & hepatology
DO  - 10.1016/s2468-1253(26)00077-4
UR  - https://doi.org/10.1016/s2468-1253(26)00077-4
ER  -

APA

JF, C., H, M., K, H., P, M., T, M., MED, A., QM, A., MJ, A., L, A., V, A., PN, B., CD, B., TM, C., L, C., D, F., T, H., V, H., H, J., W, L., D, M., S, M., Y, M., J, M., A, M., B, M., R, P., I, P., J, P., M, P., T, R., IA, R., F, S., F, S., A, S., NN, T., E, T., E, V., JW, T., & W, A. (2026). The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.. The lancet. Gastroenterology & hepatology. https://doi.org/10.1016/s2468-1253(26)00077-4

Source records

pubmed · retrieved 2026-09-26T05:06:55.088Z
europe-pmc · retrieved 2026-09-26T05:06:55.108Z